Non-clinical safety assessment of homeopathic medicinal products: criteria for establishing a first safe dilution

被引：0
|
作者：
Buchholzer, M. -L. [1 ]
Werner, C. [1 ]
Knoess, W. [1 ]
机构：
[1] BfArM Bundesinst Arzneimittel & Med Prod Zulassun, D-53175 Bonn, Germany
来源：
NAUNYN-SCHMIEDEBERGS ARCHIVES OF PHARMACOLOGY | 2012年 / 385卷
关键词：
D O I：
暂无
中图分类号：
R9 [药学];
学科分类号：
1007 ;
摘要：
066
引用
收藏
页码：17 / 17
页数：1
相关论文
共 48 条
  • [11] Non-clinical safety assessment of gadoteric acid (Dotarem®) in the neonatal and juvenile rat
    Bourrinet, Philippe
    Giorgi, Herve
    Bruffaux, Jean-Paul
    Ammerman, Jennifer
    Fretellier, Nathalie
    Corot, Claire
    [J]. TOXICOLOGY LETTERS, 2014, 229 : S89 - S90
  • [12] Non-clinical safety assessment of Annona atemoya leaf extract: evaluation of genotoxicity
    Sohn, Eunjin
    Kim, Bu-Yeo
    Kim, Yu Jin
    Jeong, Soo-Jin
    [J]. TOXICOLOGICAL RESEARCH, 2024, 40 (03) : 473 - 485
  • [13] Designing non-clinical safety evaluation programmes for gene therapy products: A personal view
    MacDonald, J
    Morrissey, R
    Patrick, J
    [J]. SAFETY EVALUATION OF BIOTECHNOLOGICALLY-DERIVED PHARMACEUTICALS: FACILITATING A SCIENTIFIC APPROACH, 1998, : 115 - 128
  • [14] Non-clinical safety evaluation of novel vaccines and adjuvants: new products, new strategies
    Brennan, FR
    Dougan, G
    [J]. VACCINE, 2005, 23 (24) : 3210 - 3222
  • [15] Similar biological medicinal products currently licensed in the European union - Overview of non-clinical study programs
    Heim, Hans-Karl
    [J]. BIOLOGICALS, 2011, 39 (05) : 284 - 288
  • [16] Safety pharmacology: an essential interface of pharmacology and toxicology in the non-clinical assessment of new pharmaceuticals
    Claude, JR
    Claude, N
    [J]. TOXICOLOGY LETTERS, 2004, 151 (01) : 25 - 28
  • [17] Strategic considerations on the design and choice of animal models for non-clinical investigations of cell-based medicinal products
    Lehmann, Joerg
    Schulz, Ronny M.
    Sanzenbacher, Ralf
    [J]. BUNDESGESUNDHEITSBLATT-GESUNDHEITSFORSCHUNG-GESUNDHEITSSCHUTZ, 2015, 58 (11-12) : 1215 - 1224
  • [18] Opportunities to meet clinical cardio-oncology needs with new approaches to non-clinical safety assessment
    Berridge, Brian R.
    Pettit, Syril D.
    Sarazan, R. Dustan
    [J]. PROGRESS IN PEDIATRIC CARDIOLOGY, 2014, 36 (1-2) : 31 - 32
  • [19] Designing non-clinical safety evaluation programmes for interferons and interleukins: Past experiences and recommendations for future products
    Cavagnaro, JA
    Anderson, T
    [J]. SAFETY EVALUATION OF BIOTECHNOLOGICALLY-DERIVED PHARMACEUTICALS: FACILITATING A SCIENTIFIC APPROACH, 1998, : 139 - 149
  • [20] Multi-criteria decision analysis for the assessment of non-clinical hospital services: Methodology and case study
    Lasorsa, Irene
    Padoano, Elio
    Marceglia, Sara
    Accardo, Agostino
    [J]. OPERATIONS RESEARCH FOR HEALTH CARE, 2019, 23
12345